期刊文献+

N-乙酰半胱氨酸联合小剂量茶碱治疗稳定期COPD的疗效观察 被引量:1

Observation of Treatment Effect in COPD with N-acetyl Cysteine and Small Dose of Theophylline
下载PDF
导出
摘要 目的:旨在探讨抗氧化剂N-乙酰半胱氨酸联合小剂量茶碱治疗轻中度稳定期COPD患者的疗效及安全性。方法:将133例稳定期轻中度COPD患者随机分为试验组63例和对照组70例,试验组服用茶碱缓释片(0.1 g,每12小时一次)+N-乙酰半胱氨酸(NAC)(600 mg,1次/d);对照组服用茶碱缓释片(0.1 g,每12小时一次)。疗程均为24周。治疗前、治疗24周后,对患者行肺功能检测及CAT评分,治疗期间记录疾病急性加重的次数及是否出现不良事件。结果:治疗24周后与治疗前比较,两组的肺功能各项指标均无明显改变(P<0.05)。两组CAT评分较治疗前均有所改善,试验组CAT评分改善情况优于对照组,且试验组AECOPD发生次数明显少于对照组,差异均有统计学意义(P<0.05)。安全性方面,用药期间的不良事件主要表现为胃肠道不适、手震、心悸、皮疹等。以上症状均较轻,两组间不良事件发生率比较差异均无统计学意义(P>0.05)。结论:N-乙酰半胱氨酸联合小剂量茶碱能有效改善COPD患者的生活质量,对于轻中度稳定期的COPD患者来说,是行之有效的安全的治疗方法。 Objective: To explore the treatment effect in COPD with N-acetyl cysteine and small dose of theophylline. Method: 133 mild-to-moderate COPD patients were randomly divided into the treatment group for 63 cases and the control group for 70 cases. The treatment group patients taken theophylline 0.1 g q12 h + N -acetylcysteine ( NAC ) 600 mg qd. The control group was given theophylline 0.1 g q12 h. Before and after 24 weeks treatment pulmonary function test and CAT scores of the two groups were detected. The numbers of AECOPD and adverse events were recorded. Result: In terms of lung function index, two groups of 24 weeks after treatment was compared with before treatment, there was no significant difference between the two groups ( P〉0.05 ) . The quality of life, CAT score of two groups after treatment were improved, CAT score in the treatment group were superior to those in the control group, and the incidences of AECOPD in the treatment group significantly less than those in the control group ( P〈0.05 ) . The main adverse e^ents were gastrointestinal discomfort, hand shake, heart palpitations, skin rash, etc. These symptoms were lighter, incidence of adverse events between the two groups was no statistically significant difference (P〉0.05) .Conclusion: N-acetyl cysteine in combination with small dose of theophyllinc can effectively improve the quality of life of patients with COPD. For patients with mild-to-moderate COPD, N-acetyl cysteine in combination with small dose of theophylline is a safe and effective treatment method.
出处 《中国医学创新》 CAS 2014年第21期92-95,共4页 Medical Innovation of China
基金 广东省科技厅研究基金资助项目(00317761120224027)
关键词 N-乙酰半胱氨酸 茶碱 慢性阻塞性肺病 N-acetylcysteine Theophylline Chronic obstructive pulmonary disease
  • 相关文献

参考文献15

  • 1Global Initiative for Chronic Obstructive Lung Disease.Global strategy for diagnosis, management, and prevention of COPD[EB/OL]. ( 2013- 11-20 ) [2011-01-20].http://www.goldcopd.org.
  • 2Repine J E, Bast A, Lankhorst I, et al.Oxidative stress in chronicobstructive pulmonary disease[J].Am, Respir Crit Care Med, 1997, 156 (32) : 341-357.
  • 3Rahman I, MacNee W.Antioxidant pharmacological therapies for COPD[J].Curr Opin Pharmaeol, 2012, 12 ( 3 ) : 256-265.
  • 4付英霞,王希柱,袁亚军,尹辉,王丽娜.N-乙酰半胱氨酸治疗慢性阻塞性肺疾病的对照研究[J].医学研究杂志,2010,39(4):97-100. 被引量:7
  • 5Decramer M, Rutten-van Molken M, Dekhuijzen P N, et al.Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS ) : a randomized placebo-controlled trial[J].Lancet, 2005, 365 (9470): 1552-1560.
  • 6Tse H N, Raiteri L, Wong K Y, et al.Benefits of high dose N-aeetylcysteine to exacerbation-prone COPD patients[J].Chest, 2014, 15 (13):2784.
  • 7马春兰,陈红,梁斌苗,冯玉麟.N-乙酰半胱氨酸对慢性阻塞性肺疾病稳定期作用的Meta分析[J].中国循证医学杂志,2011,11(10):1156-1160. 被引量:22
  • 8王喜聪.N-乙酰半胱氨辅助治疗慢性阻塞性肺疾病36例疗效评价[J].航空航天医药,2010,21(4):560-560. 被引量:6
  • 9De Backer J, Vos W, Van Holsbeke C, et al.Effect of high-dose N-acetylcysteine on airway geometry, inflammation, and oxidative stress in COPD patients[J].Int J Chron Obstruct Pulmon Dis, 2013, 8 ( 5 ) : 569-579.
  • 10Rzuin D, Palamidese A, Negrin R, et al.High-Dose N-acetylcysteine in COPD exacerbations[J].Clin Drug Invest, 2005, 2 (6) : 401- 408.

二级参考文献41

  • 1雷玲,钟小宁.N-乙酰半胱氨酸的抗氧化特性及对慢性阻塞性肺疾病的治疗作用[J].国际呼吸杂志,2006,26(5):388-391. 被引量:21
  • 2李凡,徐晓雯,邹瑾,沈菊芳,蔡映云.慢性阻塞性肺疾病患者病情变化的肺功能评价[J].中国全科医学,2007,10(11):926-927. 被引量:5
  • 3陈灏珠,林果为.实用内科学[M].13版.北京:人民卫生出版社,2009:919.
  • 4Niederman NS,McCombs JS,Unger AN,et al.Treatment cost of acute exacerbation of chronic bronchitis[J].Clin Ther,1999,21(3):576-591.
  • 5Poole P J,Black P N.Oral mucolytic drugs for exacerbation of COPD:systematic review[J].BMJ,2001,332(7297):1271-1274.
  • 6Peal R,Calcagni A M,Subiaco S,et al.N-acetylcysteine reduce the exacerbation rate in patients with moderate to severe COPD[J].Reration,1999,66:495-500.
  • 7Global Initiative for Chronic Obstructive Lung Disease.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease:GOLD executive summary.Am J Respir Crit Care Med,2007,176 (6):532-555.
  • 8Repine JE,Bast A,Lankhorst I,et al.Oxidative stress in chronic obstructive pulmonary disease.Am J Respir Crit Care Med,1997,156(32):341-357.
  • 9Macnee W,Rahman I.Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease.Am J Respir Crit Care Med,1999,160(5):S58-S65.
  • 10Pela R,Calcagni AM,Subiaco S,et al.N-acetylcysteine reduces the exacerbation rate in patients with moderate to severe COPD.Respir,1999,66 (6):495-500.

共引文献74

同被引文献19

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部